CSIR initiative to develop low-cost TB medicines
NEW DELHI: The Council of Scientific and Industrial Research on Monday launched a new initiative to develop low cost drugs for infectious diseases like tuberculosis that afflict mainly the poor in India and other developing countries. Big pharmaceutical companies do not spare much resources for these for want of adequate returns. The initiative is in the form of a web portal, which would provide a platform for researchers in the academia, industry and institutes across the world to share their knowledge and ideas and conduct collaborative research on a voluntary basis.